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ABSTRACT 
Background: Periprocedural myocardial injury (PMI) occurs in at least a third of patients 
underwent elective percutaneous coronary intervention (PCI). Effect of remote ischemic 
preconditioning (rIPC) on the PMI and infarction remains elusive. Purpose of this study was to know 
the effect of rIPC on the PMI and infarction during PCI in patient with coronary artery disease (CAD) 
underwent elective PCI. Method: Forty-two patients with stable coronary artery disease underwent 
elective PCI were randomized into rIPC group (n= 20) and control group (n=22). RIPC protocol was 4 
cycles of inflation-deflation using a blood pressure cuff 20 mmHg above the systolic blood pressure in 
one of the upper arm. Assessment of PMI was determined by increase of cardiac enzyme CK-MB at 
18 to 24 hours post PCI. Result: The levels of CK-MB post PCI was significantly lower in the RIPC 
group than control, 25.15±5.46 vs. 40.59±21.16 µg/mL, respectively ("=0.003). Evidence of PMI was 
significant lower in the RIPC group than that of the control, 2.3% vs.19.04%	("=0.022), while that of 
the infarction was not significant difference between both groups, 0% vs. 2 (4.76%), respectively 
("=0.489). Conclusion: Remote ischemic preconditioning may reduce periprocedural myocardial 
injury in patient with CAD underwent elective percutaneous coronary intervention. 
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It is known that periprocedural myocardial 
injury (PMI) is a common complication in patient 
undergoing percutaneous coronary intervention 
(PCI).1 The incidence of PMI in patients 
underwent elective PCI is 15 to 40%.2,3  PMI is any 
elevation of creatine kinase myocardial band (CK-
MB) above the upper normal limit post PCI.4 
Periprocedural myocardial injury in elective PCI 
is also correlated with an elevated mortality risk, 
risk of recurrent infarction and need for 
revascularization in the future. Although the 
blood flow at epicardial level is in the range of 
normal and PCI is considered successful, a 
disturbance in microcirculation level evidenced by 
a slight increment in CK-MB level is correlated 
with a long term cardiovascular prognosis.5-7  
There are several strategies to avoid a 
periprocedural myocardial injury. They are 
including strategy to prevent side branch 
occlusion, strategy to prevent distal embolization 
and microvascular coagulation, and strategy to 
protect myocardium.3 Remote ischemic 
preconditioning (rIPC) is a method applying sub-
lethal ischemic to target organs remote from the 
heart, such as small bladder, kidney, and the most 
non-invasive organ are the lower and upper 
extremities. rIPC decreases ischemic 
complication in both percutaneous coronary 
intervention and cardiac surgery procedure.8,9 
This procedure is safe, physiologic, non-invasive, 
simple, and inexpensive non-pharmacological 
method and potentially reduce periprocedural 
myocardial injury event. Patients with coronary 
artery disease (CAD) underwent PCI have risks 
for periprocedural myocardial injury and 
infarction, and this study found that remote 
ischemic preconditioning reduce periprocedural 
myocardial injury in patient PCI. However, the 
effect of rIPC remains elusive, and this study 
found that this rIPC reduce periprocedural 
myocardial injury but not infarction.  
 
METHODS 
Subject and design of study 
This study was quasi-experimental, pre-
posttest with control group design, in one center 
(Dr. Kariadi General Hospital, Semarang, 
Indonesia). Subjects of study were allocated into 
either intervention or control group by a simple 
randomization. Informed consent for 
participation in this study was obtained and the 
investigation was approved by the institutional 
ethics committee of human research in the 
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Faculty of Medicine Diponegoro University and 
conformed with the principles outlined in the 
Declaration of Helsinki.10 
The eligible subjects for inclusion in the study 
was patients with stable CAD underwent elective 
PCI. Patients with an increase of CK-MB level 
prior the PCI, acute coronary syndrome, chronic 
total occlusion (CTO) lesion, unstable 
hemodynamic (systolic blood pressure <90 mmHg 
and/or pulmonary edema),  severe renal disease 
(creatinine serum level above 2.5 mg/dl),  
peripheral vascular disease,  myo-skeletal injury 
or disease, malignancy, ore more than 70 years old 
were excluded from this study.  
The baseline serum CK-MB was taken prior 
the PCI.11 In the intervention group, 	a one hour 
rIPC prior PCI was performed by using a blood 
pressure cuff in the arm without intravenous line. 
The blood cuff was inflated 20 mmHg above 
patient’s systolic blood pressure for 5 minutes, 
and then deflated for 5 minutes. This intervention 
was done for 4 cycles of ischemia-reperfusion.12 
The subject was dropped out if the PCI was 
postponed for more than 3 hours post rIPC 
protocol.13 Angiographic characteristic and 
procedure, including lesion type, blood vessel 
target, pre-dilatation pressure and duration, 
length of stent, type of stent, thrombolysis in 
myocardial infarction (TIMI) flow post stent 
insertion, and complication post PCI were noted 
during PCI. Stent was inserted properly based on 
the clinical practice. All patients received bolus 
intravenous injection of unfractionated heparin 
with dose 70-100 %&/kg body weight. The second 
bolus heparin was given to maintain activated 
clotting time >250 seconds. Angiographic success 
was defined as residual stenosis <20% at the end 
of angiographic based on visual estimation. 
Procedural success was based on angiographic 
data and no major complication during 
hospitalization (acute myocardial infarction, need 
for emergency coronary artery bypass surgery or 
death). Complication after PCI was recorded. 
Those complication included side branch 
occlusion, dissection, distal embolization, 
arrhythmia, emergency coronary artery bypass 
surgery, acute myocardial infarction or death 
during hospitalization. Assessment of CK-MB 
level was done at 18 to 24 hours post PCI.14,15 
 
Statistical analysis 
SPSS software version 20.0 (Polar Engineering 
and Consulting, USA) was used for the statistical 
analysis. Mean differences between CK-MB level 
prior and post PCI were analyzed using the 
independent t-test or Mann-Whitney test as 
appropriate for continuous variables. The χ2 test 
or Fisher’s exact test was used as appropriate to 
compare categorical variables. The data were 
expressed in mean±SD. Differences with a p value 
of <0.05 were considered statistically significant.  
 
RESULT 
Baseline Characteristics 
A total of 68 patients with CAD underwent 
elective PCI were enrolled. Nineteen patients 
were excluded and 7 patients were dropped out, 
and thus 42 patients were included for further 
analysis. They were randomized into intervention 
group (20 patients) and control group (22 
patients). RIPC protocol was done successfully in 
all patients in the intervention group with no 
clinical evidence of arterial embolism, vein 
thromboembolism, or another complication. 
Clinical characteristics of subjects were shown in 
Table 1. The average of age was 58.47±5.96 years 
old. The most patients (78.5%) were male.   
 
1.1 Angiographic and Procedural Characteristics  
Most of patients had a single vessel stenting, 
including 13 (59.1%) patients in control group and 
11 (55%) patients in intervention group (Table 2). 
The B type lesion based on the American Heart 
Association/ American College of Cardiology 
(AHA/ACC) criteria was found frequently in both 
groups. The number of drug eluting stents (DES) 
used was higher than non-DES, and they were 
placed mostly at left anterior descending artery 
(LAD). Almost of the stent installment procedure 
were preceded by pre-dilatation steps. There were 
no significant differences in angiographic 
characteristic and procedure between the 
intervention and control groups.
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Table 1. Baseline Characteristics 
Variables Control (n=22) rIPC (n=20) p 
Age 57.73+5.57 59.30+6.4 0.400 
Male, n (%) 19 (86.3) 14 (70.0) 0.197 
Body Mass Index ± SD 22.93±2.66 24.08 ± 2.91 0.186 
LVEF (%), mean + SD 56.60+9.19 56.25 + 9.25 0.893 
  Traditional Risk factors    
       Hypertension, n (%) 20 (90.9) 17 (85) 0.656 
       Diabetes Mellitus, n (%) 10 (45.5) 14 (70) 0.108 
       Active smoker, n (%) 5 (22.7) 3 (15) 0.767 
       Family history of premature CAD,                
        n (%) 
1 (4.5) 3 (15) 0.333 
       Hypercholesterolemia, n (%) 2 (9.09) 4 (20) 0.400 
Pharmacological Therapy    
      ACE-inhibitors, n (%) 12 (54.5) 10 (50) 0.768 
Beta-blockers, n (%) 7 (31.8) 8 (40) 0.580 
Nitrates, n (%) 17 (77.2) 13 (65) 0.379 
Statin, n (%) 22 (100) 18 (90) 0.221 
ARB, n (%) 5 (22.7) 2 (10) 0.269 
Trimetazidine, n (%) 1 (4.54) 1 (5) 0.598 
Statistical analyses were done using Mann-Whitney, except for age, body mass index and LVEF were using 
independent t-test.
 Table 2. Angiographic and Procedural Characteristics 
Variables Control (n=22) rIPC (n=20) p 
Target vessel revascularization, n (%)    
1 vessel 13 (59.1) 11 (55) 0.787c 
2 vessels 7 (31.8) 8 (40)  
3 vessels 2 (9.1) 1 (5)  
Type of lesion (AHA/ACC)16, n (%)    
Type A 3 (13.6) 1 (5) 0.591 c 
Type B 14 (63.6) 15 (75)  
Type C 5 (22.8) 4 (20)  
Revascularized vessel, n (%)    
LAD 15 (68.18) 17 (85) 0.201 c 
LCx 5 (22.7) 6 (30) 0.592 c 
RCA 11 (50) 5 (25) 0.096 c 
Others 4 (18.18) 3 (15) 0.782 c 
Multi-vessels stenting, n (%) 10 (45.5) 9 (45) 0.976 c 
Stenotic percentage, %, mean+SD 84.7+7.47 81.5+7.45 0.180b 
Total stent length, mm, mean+SD 53.7+29,75 51.1+27.46 0.641 b 
Overlapped stenting, n (%) 11 (50) 9 (45) 0.746c 
Drug Eluting Stents, n (%) 10 (45.5) 14 (70) 0.108c 
Fluoroscopic time, minute, mean+SD 24.83+16.69 24.03+12.74 0.862a 
Direct stenting, n (%) 3 (13.6) 2 (10) 0.716c 
aIndependent t-test, bMann-Whitney, cChi-square 
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    Table 3. Levels of CK-MB pre and post-PCI 
 rIPC, remote Ischemic Preconditioning; LAD, Left Anterior Descending; LCx, Left Circumflex; RCA, Right 
Coronary Artery; AHA/ACC American Heart Association/ American College of Cardiology 
 
1.2 Incidence of Periprocedural Myocardial 
Infarction and Injury 
Table 3 shows that the level of CK-MB prior PCI 
was no significant difference between two groups, 
but its level post PCI was lower significantly in 
the intervention group than that of the control, 
40.59±21.16 vs. 25.15±5.46 µg/mL, 
respectively	("=0.003).  Thus, the delta level of 
CK-MB pre and post PCI was significant lower in 
the intervention group than that of the control, 
6.15±3.88 vs. 22.0±20.0 µg/mL, 
respectively	("=0.001).
 
         Table 4. Incidence of Periprocedural Myocardial Infarction and Injury 
 
 
aIndependent t-test, bMann-Whitney 
 
Furthermore, we observed periprocedural 
myocardial infarction and injury events in both 
groups. The periprocedural myocardial injury 
events were lower significantly in the 
intervention group than that of the control, 1 (2.38%) vs. 8 (19.04%), respectively ("=0.022), 
while the periprocedural myocardial infarction 
was not significant difference between the 
intervention and control groups, 0% vs. 2 (4.76%), 
respectively ("=0.489) (Table 4).   
 
DISCUSSION 
Remote ischemic preconditioning may 
potentially reduce periprocedural myocardial 
infarction and injury. The data of this study 
showed that four cycles of 5-minutes ischemia, 
followed by 5-minutes reperfusion in upper limb 
reduce the event of periprocedural myocardial 
injury in patient with CAD underwent elective 
PCI. Effects of remote ischemic 
preconditioning on myocardial injury have been 
reported by several studies, but its effectiveness 
remains elusive. Several factors affect the results, 
including the protocol used for rIPC, marker used 
to measure the outcome, subset of patients, and 
the use of cardioprotective agents such as statin. 
Cardioprotective effect of rIPC was also 
showed by four other reports. 9,17-19 All of these 
studies used the same protocol for rIPC by 
performing three cycles of 5-minutes inflations of 
a blood pressure cuff to 200 mmHg around the 
upper arm, followed by 5-minutes intervals of 
reperfusion. They showed a similar outcome that 
rIPC prior to PCI attenuates the release of cardiac 
troponin at 16 to 24 post elective PCI. Our data in 
this study showed that rIPC prior to PCI reduce 
CKMB level at 18 to 24 hours post PCI, a finding 
that concur with result from a prior study by Liu 
et al.17, while Ahmed et al.19 reported that rIPC 
did not affect the CKMB level.  
On the other hand, three studies reported that 
rIPC fails to show a significant effect on the level 
cardiac troponin release post elective PCI.20-22 
Yılmaztepe et al.20 used one cycle of 5-minutes 
inflating the blood pressure cuff up to 200 mm Hg 
Incidence Control rIPC p 
Periprocedural Myocardial Injury, n (%) 8(19.04) 1 (2.38) 0.022a 
Periprocedural Myocardial Infarction, n (%) 2 (4.76) 0 0.489a 
aFisher’s exact test    
CK-MB n Mean ± SD, iu/L p 
  Control rIPC  
Pre-PCI, mean±SD 
 
42 18.59+3.17 19.00+2.90 0.665a 
24 hour post-PCI, mean±SD 
 
42  40.59+21.16 
 
25.15+5.46 
 
0.003a 
Δ CKMB Pre-Post, mean±SD 
 
 
42 
 
22±20 
 
 
6.15+3.88 
 
 
0.001b 
     
N. Anggriyani et al . nggriyani et al 
12 
 
on the non-dominant arm which may not reach an 
optimal ischemic preconditioning for 
myocardium. While Xu et al.21 performed a 3 
cycles of 5-minute pneumatic medical cuff 
inflations to 200 mm Hg in elderly patients with 
CAD having DM. These subset of patients may 
not get benefit from rIPC prior elective PCI since 
they could have mitochondrial dysfunction 
leading to failure in response to myocardial 
preconditioning.23 Iliodromitis et al.22 also used a 
three cycles of 5-minutes ischemia-reperfusion 
with blood pressure cuff inflated to 200 mmHg, 
but at both upper limbs, which was likely to 
induce inflammation reaction, shown by increase 
of level of C-reactive protein (CRP).  
In regard with rIPC protocol, most of studies 
used a blood pressure cuff inflation to 200 mmHg 
for 5 minutes 9,17-19,22 ;however, in our clinical 
experience, this pressure is quite high and causes 
discomfort to the patients. Thus, the inflating 
blood pressure cuff 20 mmHg higher than systolic 
blood pressure in one arm was used in this study 
based on the rIPC protocol from McDonald et al.24 
which adjusted pressure according to the systolic 
blood pressure.12 Both myocardial injury markers 
troponin and CK-MB have been used in the 
measurement of effectiveness of RIPC. We used 
CK-MB in this study because of it is more relevant 
and could be used to determine a prognosis 
implication when compared to troponin.25 
The evidence of periprocedural myocardial 
infarction in this study was not significantly 
different between the intervention and control 
groups. The same finding was also reported by 
Ahmed et al.19. While Luo et al.18 found that rIPC 
reduce the evidence of myocardial infarction 
related PCI. The statistical significance could be 
resulted from the different number of participants 
involved in those studies. 
The mechanism how rIPC attenuate 
myocardial injury related PCI has been proposed 
in hypothesis. A current study found that rIPC 
induces an intracoronary increase of nitric oxide 
levels associated with a decrease in myocardial 
damage measured as no increase in cardiac 
troponin I with electrocardiographic increases in 
the sum of R waves, suggesting an improved 
myocardium after elective PCI.26  
 
CONCLUSION 
Remote ischemic preconditioning may reduce 
periprocedural myocardial injury in patient with 
coronary artery disease underwent elective 
percutaneous coronary intervention. Several prior 
reports,9,17-19,22 corroborate the finding that rIPC 
as a safe and effective strategy to protect 
myocardium during elective PCI. It could be 
applied routinely in clinical practice since it is 
non-invasive, easy, cheap, and safe procedure, 
with no complication event. 
 
STUDY LIMITATION 
Limitation of this study is that the patients who 
used intracoronary glyceryl trinitrate during PCI 
were not excluded. This agent is known to have a 
preconditioning-mimetic effect in both 
experimental group and control group.27  The CK-
MB level was measured in a single blood sample 
obtained 18 to 24 hours post PCI rather than 
defining the CK-MB release profile every 4 to 6 
hours. The resultant value may not be the 
maximum plasma concentration, although it is 
generally accepted that the maximum 
concentration occurs between 16 and 30 hours 
after myocyte necrosis. 
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